» Articles » PMID: 28680947

Beyond Endemic Burkitt Lymphoma: Navigating Challenges of Differentiating Childhood Lymphoma Diagnoses Amid Limitations in Pathology Resources in Lilongwe, Malawi

Abstract

Although Burkitt lymphoma (BL) is the most common childhood lymphoma in sub-Saharan Africa, Hodgkin lymphoma (HL) and other non-Hodgkin lymphomas occur. Diagnosing non-jaw mass presentations is challenging with limited pathology resources. We retrospectively analyzed 114 pediatric lymphomas in Lilongwe, Malawi, from December 2011 to June 2013 and compared clinical versus pathology-based diagnoses over two time periods. Access to pathology resources became more consistent in 2013 compared with 2011-2012; pathology interpretations were based on morphology only. Median age was 8.4 years (2.1-16.3). The most common anatomical sites of presentation were palpable abdominal mass 51%, peripheral lymphadenopathy 35%, and jaw mass 34%. There were 51% jaw masses among clinical diagnoses versus 11% in the pathology-based group ( < .01), whereas 62% of pathology diagnoses involved peripheral lymphadenopathy versus 16% in the clinical group ( < .01). The breakdown of clinical diagnoses included BL 85%, lymphoblastic lymphoma (LBL) 9%, HL 4%, and diffuse large B-cell lymphoma (DLBCL) 1%, whereas pathology-based diagnoses included HL 38%, BL 36%, LBL 15%, and DLBCL 11% ( < .01). Lymphoma diagnosis was pathology confirmed in 19/66 patients (29%) in 2011-2012 and 28/48 (60%) in 2013 ( < .01). The percentage of non-BL diagnoses was consistent across time periods (35%); however, 14/23 (61%) non-BL diagnoses were pathology confirmed in 2011-2012 versus 16/17 (94%) in 2013. Lymphomas other than Burkitt accounted for 35% of childhood lymphoma diagnoses. Over-reliance on clinical diagnosis for BL was a limitation, but confidence in non-BL diagnoses improved with time as pathology confirmation became standard. Increased awareness of non-BL lymphomas in equatorial Africa is warranted.

Citing Articles

Clinical application of circulating cell-free lymphoma DNA for fast and precise diagnosis of Burkitt lymphoma: Precision medicine for sub-Saharan Africa.

Chamba C, Mbulaiteye S, Balandya E, Schuh A Camb Prism Precis Med. 2024; 1:e13.

PMID: 38550928 PMC: 10953760. DOI: 10.1017/pcm.2023.1.


Update on pathology laboratory development and research in advancing regional cancer care in Malawi.

Brownlee A, Dewey M, Chagomerana M, Tomoka T, Mulenga M, Khan S Front Med (Lausanne). 2024; 11:1336861.

PMID: 38298817 PMC: 10829605. DOI: 10.3389/fmed.2024.1336861.


Treatment delays in children and young adults with lymphoma: a report from an East Africa lymphoma cohort study.

Mawalla W, Morrell L, Chirande L, Achola C, Mwamtemi H, Sandi G Blood Adv. 2023; 7(17):4962-4965.

PMID: 37171463 PMC: 10463187. DOI: 10.1182/bloodadvances.2022009398.


Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa.

Ozuah N, Lubega J, Allen C, El-Mallawany N Blood Adv. 2020; 4(16):4007-4019.

PMID: 32841337 PMC: 7448606. DOI: 10.1182/bloodadvances.2020002178.


Generalized lymphadenopathy: an unusual presentation of burkitt lymphoma in a Nigerian child: a case report.

Ezenwosu O, Chukwu B, Okafor O, Ikefuna A, Emodi I Afr Health Sci. 2020; 19(4):3249-3252.

PMID: 32127903 PMC: 7040310. DOI: 10.4314/ahs.v19i4.49.

References
1.
Orem J, Sandin S, Weibull C, Odida M, Wabinga H, Mbidde E . Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory. Clin Epidemiol. 2013; 4:339-47. PMC: 3531988. DOI: 10.2147/CLEP.S35671. View

2.
Magrath I . Lessons from clinical trials in African Burkitt lymphoma. Curr Opin Oncol. 2009; 21(5):462-8. DOI: 10.1097/CCO.0b013e32832f3dcd. View

3.
Biggar R, Frisch M, Goedert J . Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA. 2000; 284(2):205-9. DOI: 10.1001/jama.284.2.205. View

4.
Traore F, Coze C, Atteby J, Andre N, Moreira C, Doumbe P . Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (GFAOP). Pediatr Blood Cancer. 2010; 56(1):70-6. DOI: 10.1002/pbc.22746. View

5.
Caselli D, Klersy C, De Martino M, Gabiano C, Galli L, Tovo P . Human immunodeficiency virus-related cancer in children: incidence and treatment outcome--report of the Italian Register. J Clin Oncol. 2000; 18(22):3854-61. DOI: 10.1200/JCO.2000.18.22.3854. View